Published today in the Journal of the American Medical Association, the study provides the first long-term, individual-level evidence that reducing arsenic exposure may lower mortality, even among people exposed to the toxic contaminant for years.

The landmark analysis, led by researchers at Columbia University and New York University, is important for public health because groundwater contamination from naturally occurring arsenic remains a serious issue worldwide. In the United States, more than 100 million people rely on potentially contaminated groundwater sources, especially private wells, for their drinking water. Arsenic is among the most common chemical pollutants.

Despite decades of government inquiries, significant differences in palliative care remain in Sweden. A new series of studies shows that the national governance is not working as intended, and that access to end-of-life palliative care depends on where the patient lives.

A 3 months study conducted in the intensive care unit (ICU) in Japan, revealed that healthcare workers experience reduced environmental satisfaction and concentration due to lack of natural light and excessive ambient noise. When designing ICUs, architects should focus on increasing natural light and mitigating noise. These factors could help enhance healthcare worker satisfaction, productivity, and quality of patient care.

The iMetaMed framework illustrates the integrative vision for medicine by dissolving disciplinary boundaries. Four major modules are highlighted: (1) Molecular & Computational Frontiers, represented by AlphaFold3 protein structure prediction (precision diagnostics), GeneCompass federated learning, and single-cell transcriptome integration; (2) AI-Enabled Clinical Translation, including AI-driven drug discovery, virtual cell modeling, and generative virtual staining; (3) Data Science & Infrastructure, featuring big data methodologies, dual-axis slicing, semantic dictionaries, and accelerated Biobank data extraction; and (4) Health Systems & Public Impact, encompassing telemedicine applications, open science, transparent peer review, multilingual dissemination, and diversity-oriented equity frameworks. At the core, iMetaMed envisions a seamless continuum from molecules to clinical practice, population health, and policy—transforming information abundance into actionable breakthroughs for global health.